IDT Biologika is a GMP development and manufacturing organization offering services for partners committed to develop and market therapeutic and prophylactic vaccines and biological products. We use broad capabilities and a depth of technologies in collaboration with our client partners to provide end-to-end services from process development through manufacturing and fill/finish for companies involved in the development of vaccines, gene therapy and oncolytic viral therapies.
Focussed on vaccines and other biopharmaceuticals, IDT Biologika utilizes stateof-the-art facilities and offers many years of experience in the development of production processes and the commercial production of viral live vaccines. We understand your challenges and strive for strong and long-term partnerships with our clients, including multi-national pharmaceuticals, biotechs, academic and research institutions, governmental and NGO’s worldwide. We are ready to collaborate for your success.
IDT Biologika is a longstanding service provider for US government. Founded almost 100 years ago in Germany, the company operates sites in Germany (Dessau-Rosslau, and Magdeburg) and in the USA (Rockville, Maryland).
Company site in Germany is the BioPharmaPark in Dessau-Rosslau. In the United States, IDT Corporation operates a production site for clinical test samples in Rockville, Maryland.
Production, Research & Development
IDT Biologika’s significant growth was fueled by the high demand for new vaccines to combat diseases around the globe. The company achieved sales of 240.9 million euros for fiscal year 2017 (preliminary figures). IDT annually invests around six percent of its revenue in research and development of its own proprietary products. In 2017 IDT employed approximately 1,915 people worldwide.
As a global manufacturer, IDT Biologika undergoes regular inspections by clients and independent regulatory agencies, such as the European Medicines Agency (EMA) and the U.S. Food & Drug Administration (FDA). IDT Biologika’s advanced production system positions the company among the world’s leading vaccine manufacturing corporations. Pioneering technologies for the production of new vaccines and pharmaceuticals underscores IDT’s commitment to set standards for pharmaceutical production, both now and in the future. IDT Biologika’s focus on customers and operational excellence has earned the company many international awards.
IDT Biologika is a member of the Klocke Group. Klocke Group companies are specialized in contract production and packaging of medications, vaccines and cosmetic products. A traditional, family-owned company, the Klocke Group employs a workforce of more than 2,000 people in Europe and the U.S. The group offers comprehensive services for the manufacture and packaging of pharmaceutical products at its six production facilities.
For more information about the Klocke Group, visit: www.klocke.com